Manufacturer copay assistance · Gazyva (J9301) · Genentech
Eligible patients pay as… · Maximum benefit Up to $25,000/year · Covers Gazyva drug cost only — does NOT cover infusion administration or office visit fees
Published terms from the manufacturer. Per-patient eligibility is confirmed at enrollment.
This manufacturer program excludes government insurance. Foundation disease funds are the route instead — status shown as of each fund's last verification.
Run a benefits estimate for Gazyva — the program's cap applies against the patient share CareCost calculates.
Yes — Genentech Oncology Co-pay Assistance Program (Gazyva) from Genentech. Eligible patients pay as little as $0 per treatment. Commercial insurance is required; Medicare and Medicaid patients are not eligible.
Eligible patients pay as little as $0 per treatment Maximum benefit: Up to $25,000/year. Covers Gazyva drug cost only — does NOT cover infusion administration or office visit fees
Accepted insurance: commercial. Not eligible: medicare, medicaid, tricare, va, government.